Release Date: 01/11/19 11:00 Summary: Quarterly Update - September 2019 Price Sensitive: No Download Document 1.98MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%